Atomoxetine provides stimulant-free alternative for ADHD. (FDA Approval).(Strattera for treatment of attention-deficit hyperactivity disorder ): An article from: Family Practice News
|
Regular Price: |
Dear visitor! This website has been designed to help you find THE BEST PRICE. When you are ready to buy, your payment will be processed through one of the most TRUSTED SUPPLIERS directly. |
| Not what you're looking for? Try smart custom search: |
Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on January 15, 2003. The length of the article is 802 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Atomoxetine provides stimulant-free alternative for ADHD. (FDA Approval).(Strattera for treatment of attention-deficit hyperactivity disorder )
Author: Kerri Wachter
Publication: Family Practice News (Magazine/Journal)
Date: January 15, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 2 Page: 6(1)
Article Type: Product/Service Evaluation
Distributed by Thomson Gale Top to learn more


